Childhood cancers trials in China

In China 609 Also abroad 2483

609 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
Computer Vision-Based Recognition of Parathyroid Glands and Recurrent Laryngeal Nerves in Endoscopic Surgery
Where
Fuzhou
People
100
Run by
Fujian Medical University
See details and how to joinNCT07628543
Phase 2/3Taking people
Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents
Where
Shanghai
Age
Up to 18 years
People
87
Run by
Children's Cancer Group, China
See details and how to joinNCT07168980
No phaseTaking people
Association Between Screening Behaviors and Lung Cancer Spectrum
Where
Shanghai
People
5,390
Run by
Fudan University
See details and how to joinNCT07626177
No phaseTaking people
Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
Where
Beijing
People
80
Run by
Peking University People's Hospital
See details and how to joinNCT07359040
No phaseNot yet taking people in China
Structured Cardio-Oncology Rehabilitation for Cardiovascular Outcomes in Cancer Survivors
Where
Ürümqi
Age
18 months and over
People
800
Run by
Xinjiang Medical University
See details and how to joinNCT07622394
Phase 1Not yet taking people in China
Single-arm, Open-label, Dose-escalating Phase I Clinical Study of PA3-17 Injection in Children and Adolescents With Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
Where
Hefei
Age
3 years to 18 years
People
12
Run by
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
See details and how to joinNCT07623681
No phaseNot yet taking people in China
Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma
Where
Beijing
Age
12 months and over
People
55
Run by
Peking University People's Hospital
See details and how to joinNCT07620431
Phase 2Not yet taking people in China
Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma
Where
Beijing
Age
15 years and over
People
274
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07612098
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Daping, Fuzhou, Guangzhou, Hangzhou, Harbin, Hefei, Nanjing, Shanghai, Shatin, Shenyang, Shenzhen, Taiyuan, Weifang, Wuhan, Xiamen, Xi'an, Xuzhou, Zhengzhou
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
No phaseTaking people
Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:
Where
Changsha
People
500
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT07608003
No phaseTaking people
Multicentric Database for KRAS Mutant Pancreatic Cancer
Where
Shanghai
People
1,000
Run by
Fudan University
See details and how to joinNCT07557849
Phase 1Taking people
Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia
Where
Beijing, Chengdu, Shanghai
Age
1 year to 70 years
People
27
Run by
Beijing GoBroad Hospital
See details and how to joinNCT06326021
Phase 2Taking people
Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma
Where
Guangzhou
Age
14 years to 70 years
People
57
Run by
Sun Yat-sen University
See details and how to joinNCT07602049
No phaseNot yet taking people in China
Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy
Where
Beijing, Shenzhen, Taiyuan
Age
1 year and over
People
300
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07596524
Phase 2Taking people
Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study
Where
Guangzhou
Age
6 months to 18 years
People
88
Run by
Sun Yat-sen University
See details and how to joinNCT05457829
No phaseNot yet taking people in China
Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection
Where
Wuhan
People
1,000
Run by
Tongji Hospital
See details and how to joinNCT07593833
Phase 1/2Taking people
Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML
Where
Tianjin
Age
14 years and over
People
23
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06611839
Phase 2Taking people
Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML
Where
Tianjin
Age
14 years to 60 years
People
380
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06635681
No phaseTaking people
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Where
Tianjin
Age
14 years to 60 years
People
92
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07454226
Phase 1Taking people
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
Where
Guangzhou
Age
2 years to 18 years
People
51
Run by
Sun Yat-sen University
See details and how to joinNCT07584499
Phase 3Taking people
The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With DLBCL in Low Risk
Where
Shanghai
Age
14 years to 75 years
People
640
Run by
Ruijin Hospital
See details and how to joinNCT05018520
Phase 1/2Taking people
TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL
Where
Beijing, Changzhi, Tianjin
Age
16 years to 70 years
People
30
Run by
Chinese PLA General Hospital
See details and how to joinNCT06481735
Phase 2Taking people
A Multicenter RCT of "3+7" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients
Where
Beijing
Age
14 years to 75 years
People
160
Run by
Chinese PLA General Hospital
See details and how to joinNCT06928376
No phaseTaking people
Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
Where
Shanghai
People
500
Run by
Shanghai 6th People's Hospital
See details and how to joinNCT06671184
No phaseTaking people
Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)
Where
Shanghai
People
200
Run by
Shanghai 6th People's Hospital
See details and how to joinNCT06730321